Presented by: Tsai, Mu-Hung, M.D. Department of Radiation Oncology, National Cheng Kung University Hospital 2016/09/02
Presented by:
Tsai, Mu-Hung, M.D.Department of Radiation Oncology, National Cheng Kung University Hospital
2016/09/02
Lung Cancer Most prevalent cancer worldwide Histopathological classification
Small cell carcinoma Non-small cell carcinoma
Squamous cell carcinoma Adenocarcinoma
Grade (Gr.1 – Gr.3) Low level of inter-observer agreement
PathologySquamous cell carcinoma Adenocarcinoma
Aim Fully automated microscopic pathology image features
Predict lung cancer survival
Training
Validation
Methods & Materials The Cancer Genome
Atlas (TCGA) Stanford Tissue
Microarray (TMA) Database
Cross-validate
Image: euthman @ Flickr
Results
Identifying Tumor
Adenocarcinoma vs. Normal Lung
SCC vs. Normal Lung
Adenocarcinoma vs. SCC (TCGA)
Adenocarcinoma vs. SCC (TMA)
Results
Predicting Survival
Predicting Adenocarcinoma Prognosis
Stage IB Grade 3 adenocarcinoma
Predicting SCC Prognosis
Discussion Automated workflow to analyze whole slide pathology
Elastic net-Cox proportional hazards models Computationally efficient Handles right-censored survival data
Performance not very sensitive to ML method
Obtain large number of features!